No abstract

information on the apparent lack of efficacy of sugammadex in the management of rocuronium-induced anaphylaxis. This is consistent with in-vivo experiments and a rational appraisal of the pathophysiology of anaphylaxis [2, 3]. This is the first study that has examined the efficacy of sugammadex in presumed anaphylaxis that includes a control group. As we provided all our data in a summary table, as well as comprehensive case details in the online version of the article, readers will be able to formulate their own conclusions.

No abstract